Its weight-loss drug policy would fall to Trump's pick for health secretary, Robert F Kennedy Jr, and Mehmet Oz, Trump's ...
A serial entrepreneur and a promising drug emerge from failed companies to pursue subsets of obesity patients, with or ...
Eli Lilly's Ozempic-rivaling weight-loss pill orforglipron could be available in early 2026. Its retatrutide may be as ...
Weight-loss medicines such as Ozempic might raise a person’s likelihood of developing conditions including arthritis.
Shares in Novo Nordisk were up nearly 12% today – hiking its valuation to more than $280 billion – after it reported new clinical data with one of its obesity drug candidates. The new results ...
A study by the Department of Veterans Affairs says that drugs like Ozempic can do plenty more than just help with weight loss ...
T he newest weight-loss drugs, Wegovy and Zepbound, are incredibly popular. But doctors are still learning about all of the ...
Major heart health risk factors like obesity, diabetes and high blood pressure remain on the rise in the United States, ...
Right now, patients with obesity and cirrhosis have few treatments for their progressive liver disease, but a new study ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback